Xenon Pharmaceuticals Inc. 4
4 · Xenon Pharmaceuticals Inc. · Filed Apr 4, 2016
Insider Transaction Report
Form 4
WINQUIST RAYMOND
Head, Translational Research
Transactions
- Award
Stock Option (Right to Buy)
2016-04-04+35,000→ 35,000 totalExercise: $7.10Exp: 2026-04-03→ Common Shares (35,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on April 4, 2017, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.